ReposiTrak (TRAK) EPS (Weighted Average and Diluted) (2016 - 2025)
ReposiTrak has reported EPS (Weighted Average and Diluted) over the past 12 years, most recently at $0.09 for Q4 2025.
- Quarterly results put EPS (Weighted Average and Diluted) at $0.09 for Q4 2025, up 12.5% from a year ago — trailing twelve months through Dec 2025 was $0.37 (up 15.63% YoY), and the annual figure for FY2025 was $0.35, up 20.69%.
- EPS (Weighted Average and Diluted) for Q4 2025 was $0.09 at ReposiTrak, roughly flat from $0.09 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for TRAK hit a ceiling of $0.1 in Q1 2025 and a floor of $0.03 in Q1 2021.
- Median EPS (Weighted Average and Diluted) over the past 5 years was $0.07 (2023), compared with a mean of $0.07.
- Peak annual rise in EPS (Weighted Average and Diluted) hit 200.0% in 2021, while the deepest fall reached 50.0% in 2021.
- ReposiTrak's EPS (Weighted Average and Diluted) stood at $0.04 in 2021, then soared by 50.0% to $0.06 in 2022, then grew by 16.67% to $0.07 in 2023, then increased by 14.29% to $0.08 in 2024, then grew by 12.5% to $0.09 in 2025.
- The last three reported values for EPS (Weighted Average and Diluted) were $0.09 (Q4 2025), $0.09 (Q3 2025), and $0.09 (Q2 2025) per Business Quant data.